{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:30:10Z","timestamp":1770751810599,"version":"3.50.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-025-01418-9","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:03:36Z","timestamp":1768453416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of low molecular weight protein tyrosine phosphatase in gastric cancer and its association with clinical outcomes and oncogenic hallmarks"],"prefix":"10.1186","volume":"32","author":[{"given":"Luochengling","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maikel\u00a0 P.","family":"Peppelenbosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenny M.","family":"Fuhler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"1418_CR35","doi-asserted-by":"publisher","first-page":"e2400444","DOI":"10.1200\/po-24-00444","volume":"8","author":"N Abdallah","year":"2024","unstructured":"Abdallah N, Elliott A, Smith N, et al. Dissecting the significance of acid phosphatase 1 gene alterations in prostate cancer. JCO Precis Oncol Oct. 2024;8:e2400444. https:\/\/doi.org\/10.1200\/po-24-00444.","journal-title":"JCO Precis Oncol Oct"},{"issue":"9","key":"1418_CR2","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.12998\/wjcc.v8.i9.1608","volume":"6","author":"A Alshehri","year":"2020","unstructured":"Alshehri A, Alanezi H, Kim BS. Prognosis factors of advanced gastric cancer according to sex and age. World J Clin Cases May. 2020;6(9):1608\u201319. https:\/\/doi.org\/10.12998\/wjcc.v8.i9.1608.","journal-title":"World J Clin Cases May"},{"issue":"8","key":"1418_CR22","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/jci91190","volume":"1","author":"M Ayers","year":"2017","unstructured":"Ayers M, Lunceford J, Nebozhyn M, et al. IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 Blockade. J Clin Invest Aug. 2017;1(8):2930\u201340. https:\/\/doi.org\/10.1172\/jci91190.","journal-title":"J Clin Invest Aug"},{"key":"1418_CR20","doi-asserted-by":"publisher","unstructured":"Bai X, Wong CC, Pan Y, et al. Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells. J Immunother Cancer Feb. 2022;10(2). https:\/\/doi.org\/10.1136\/jitc-2021-003663.","DOI":"10.1136\/jitc-2021-003663"},{"issue":"1","key":"1418_CR21","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"4","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, et al. QuPath: open source software for digital pathology image analysis. Sci Rep Dec. 2017;4(1):16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5.","journal-title":"Sci Rep Dec"},{"issue":"9","key":"1418_CR8","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1158\/1078-0432.Ccr-16-0934","volume":"1","author":"LR Bollu","year":"2017","unstructured":"Bollu LR, Mazumdar A, Savage MI, Brown PH. Molecular pathways: targeting protein tyrosine phosphatases in cancer. Clin Cancer Res May. 2017;1(9):2136\u201342. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-0934.","journal-title":"Clin Cancer Res May"},{"issue":"1","key":"1418_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0014-5793(99)00828-5","volume":"30","author":"M Bucciantini","year":"1999","unstructured":"Bucciantini M, Chiarugi P, Cirri P, et al. The low Mr phosphotyrosine protein phosphatase behaves differently when phosphorylated at Tyr131 or Tyr132 by Src kinase. FEBS Lett Jul. 1999;30(1):73\u20138. https:\/\/doi.org\/10.1016\/s0014-5793(99)00828-5.","journal-title":"FEBS Lett Jul"},{"issue":"7517","key":"1418_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Comprehensive molecular characterization of gastric adenocarcinoma","year":"2014","unstructured":"Comprehensive molecular characterization of gastric adenocarcinoma. Nature Sep 11. 2014;513(7517):202\u20139. https:\/\/doi.org\/10.1038\/nature13480.","journal-title":"Nature Sep 11"},{"key":"1418_CR23","doi-asserted-by":"publisher","unstructured":"Cristescu R, Mogg R, Ayers M, et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science Oct. 2018;12(6411). https:\/\/doi.org\/10.1126\/science.aar3593.","DOI":"10.1126\/science.aar3593"},{"issue":"9","key":"1418_CR3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","volume":"24","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah H, El Masri J, Fakhereddine H, et al. Colorectal cancer: recent advances in management and treatment. World J Clin Oncol Sep. 2024;24(9):1136\u201356. https:\/\/doi.org\/10.5306\/wjco.v15.i9.1136.","journal-title":"World J Clin Oncol Sep"},{"issue":"1","key":"1418_CR16","doi-asserted-by":"publisher","first-page":"166280","DOI":"10.1016\/j.bbadis.2021.166280","volume":"1","author":"AVS Faria","year":"2022","unstructured":"Faria AVS, Yu B, Mommersteeg M, et al. Platelet-dependent signaling and low molecular weight protein tyrosine phosphatase expression promote aggressive phenotypic changes in Gastrointestinal cancer cells. Biochim Biophys Acta Mol Basis Dis Jan. 2022;1(1):166280. https:\/\/doi.org\/10.1016\/j.bbadis.2021.166280.","journal-title":"Biochim Biophys Acta Mol Basis Dis Jan"},{"issue":"2","key":"1418_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbrc.2006.07.091","volume":"22","author":"E Giannoni","year":"2006","unstructured":"Giannoni E, Raugei G, Chiarugi P, Ramponi G. A novel redox-based switch: LMW-PTP oxidation enhances Grb2 binding and leads to ERK activation. Biochem Biophys Res Commun Sep. 2006;22(2):367\u201373. https:\/\/doi.org\/10.1016\/j.bbrc.2006.07.091.","journal-title":"Biochem Biophys Res Commun Sep"},{"key":"1418_CR37","doi-asserted-by":"publisher","first-page":"104616","DOI":"10.1016\/j.ebiom.2023.104616","volume":"92","author":"T Hess","year":"2023","unstructured":"Hess T, Maj C, Gehlen J, et al. Dissecting the genetic heterogeneity of gastric cancer. EBioMedicine Jun. 2023;92:104616. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104616.","journal-title":"EBioMedicine Jun"},{"issue":"1","key":"1418_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbcan.2012.04.001","volume":"1826","author":"E Hoekstra","year":"2012","unstructured":"Hoekstra E, Peppelenbosch MP, Fuhler GM. The role of protein tyrosine phosphatases in colorectal cancer. Biochim Biophys Acta Aug. 2012;1826(1):179\u201388. https:\/\/doi.org\/10.1016\/j.bbcan.2012.04.001.","journal-title":"Biochim Biophys Acta Aug"},{"issue":"10","key":"1418_CR15","doi-asserted-by":"publisher","first-page":"8300","DOI":"10.18632\/oncotarget.3224","volume":"10","author":"E Hoekstra","year":"2015","unstructured":"Hoekstra E, Kodach LL, Das AM, et al. Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer. Oncotarget Apr. 2015;10(10):8300\u201312. https:\/\/doi.org\/10.18632\/oncotarget.3224.","journal-title":"Oncotarget Apr"},{"issue":"17","key":"1418_CR34","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1016\/j.cell.2024.07.037","volume":"22","author":"D Hollern","year":"2024","unstructured":"Hollern D. Memory B cell fitness and anergy has significant links to cancer lethality. Cell Aug. 2024;22(17):4551\u20133. https:\/\/doi.org\/10.1016\/j.cell.2024.07.037.","journal-title":"Cell Aug"},{"issue":"6","key":"1418_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/bjc.2017.245","volume":"5","author":"P Jim\u00e9nez Fonseca","year":"2017","unstructured":"Jim\u00e9nez Fonseca P, Carmona-Bayonas A, Hern\u00e1ndez R, et al. Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National cancer registry. Br J Cancer Sep. 2017;5(6):775\u201382. https:\/\/doi.org\/10.1038\/bjc.2017.245.","journal-title":"Br J Cancer Sep"},{"key":"1418_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P, The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type. carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31\u201349. https:\/\/doi.org\/10.1111\/apm.1965.64.1.31.","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"1","key":"1418_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/sla.0000000000002040","volume":"267","author":"JH Lee","year":"2018","unstructured":"Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg Jan. 2018;267(1):105\u201313. https:\/\/doi.org\/10.1097\/sla.0000000000002040.","journal-title":"Ann Surg Jan"},{"issue":"3","key":"1418_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.bbrc.2005.06.176","volume":"2","author":"F Malentacchi","year":"2005","unstructured":"Malentacchi F, Marzocchini R, Gelmini S, et al. Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers. Biochem Biophys Res Commun Sep. 2005;2(3):875\u201383. https:\/\/doi.org\/10.1016\/j.bbrc.2005.06.176.","journal-title":"Biochem Biophys Res Commun Sep"},{"issue":"9","key":"1418_CR31","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s00268-002-6344-2","volume":"26","author":"D Marrelli","year":"2002","unstructured":"Marrelli D, Roviello F, de Manzoni G, et al. Different patterns of recurrence in gastric cancer depending on lauren\u2019s histological type: longitudinal study. World J Surg Sep. 2002;26(9):1160\u20135. https:\/\/doi.org\/10.1007\/s00268-002-6344-2.","journal-title":"World J Surg Sep"},{"issue":"7","key":"1418_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol Jul. 2019;37(7):773\u201382. https:\/\/doi.org\/10.1038\/s41587-019-0114-2.","journal-title":"Nat Biotechnol Jul"},{"issue":"11","key":"1418_CR26","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc Nov. 2013;8(11):2281\u2013308. https:\/\/doi.org\/10.1038\/nprot.2013.143.","journal-title":"Nat Protoc Nov"},{"issue":"44","key":"1418_CR19","doi-asserted-by":"publisher","first-page":"41631","DOI":"10.1074\/jbc.M201709200","volume":"1","author":"S Rigacci","year":"2002","unstructured":"Rigacci S, Rovida E, Dello Sbarba P, Berti A. Low Mr phosphotyrosine protein phosphatase associates and dephosphorylates p125 focal adhesion kinase, interfering with cell motility and spreading. J Biol Chem Nov. 2002;1(44):41631\u20136. https:\/\/doi.org\/10.1074\/jbc.M201709200.","journal-title":"J Biol Chem Nov"},{"issue":"4","key":"1418_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.eururo.2015.06.040","volume":"69","author":"RR Ruela-de-Sousa","year":"2016","unstructured":"Ruela-de-Sousa RR, Hoekstra E, Hoogland AM, et al. Low-Molecular-Weight protein tyrosine phosphatase predicts prostate cancer outcome by increasing the metastatic potential. Eur Urol Apr. 2016;69(4):710\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2015.06.040.","journal-title":"Eur Urol Apr"},{"issue":"12","key":"1418_CR27","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1158\/2159-8290.Cd-20-0522","volume":"10","author":"D Sha","year":"2020","unstructured":"Sha D, Jin Z, Budczies J, Kluck K, Stenzinger A, Sinicrope FA. Tumor mutational burden as a predictive biomarker in solid tumors. Cancer Discov Dec. 2020;10(12):1808\u201325. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-0522.","journal-title":"Cancer Discov Dec"},{"issue":"6","key":"1418_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nchembio.2344","volume":"13","author":"SM Stanford","year":"2017","unstructured":"Stanford SM, Aleshin AE, Zhang V, et al. Diabetes reversal by Inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol Jun. 2017;13(6):624\u201332. https:\/\/doi.org\/10.1038\/nchembio.2344.","journal-title":"Nat Chem Biol Jun"},{"issue":"5","key":"1418_CR14","doi-asserted-by":"publisher","first-page":"eadg7887","DOI":"10.1126\/sciadv.adg7887","volume":"2","author":"SM Stanford","year":"2024","unstructured":"Stanford SM, Nguyen TP, Chang J, et al. Targeting prostate tumor low-molecular weight tyrosine phosphatase for oxidation-sensitizing therapy. Sci Adv Feb. 2024;2(5):eadg7887. https:\/\/doi.org\/10.1126\/sciadv.adg7887.","journal-title":"Sci Adv Feb"},{"issue":"3","key":"1418_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin May. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin May"},{"issue":"9","key":"1418_CR11","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1074\/jbc.272.9.5371","volume":"28","author":"P Tailor","year":"1997","unstructured":"Tailor P, Gilman J, Williams S, Couture C, Mustelin T. Regulation of the low molecular weight phosphotyrosine phosphatase by phosphorylation at tyrosines 131 and 132. J Biol Chem Feb. 1997;28(9):5371\u20134. https:\/\/doi.org\/10.1074\/jbc.272.9.5371.","journal-title":"J Biol Chem Feb"},{"key":"1418_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejca.2020.02.017","volume":"130","author":"RT van der Kaaij","year":"2020","unstructured":"van der Kaaij RT, Koemans WJ, van Putten M, et al. A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015. Eur J Cancer May. 2020;130:23\u201331. https:\/\/doi.org\/10.1016\/j.ejca.2020.02.017.","journal-title":"Eur J Cancer May"},{"issue":"11","key":"1418_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrclinonc.2013.170","volume":"10","author":"R Wadhwa","year":"2013","unstructured":"Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol Nov. 2013;10(11):643\u201355. https:\/\/doi.org\/10.1038\/nrclinonc.2013.170.","journal-title":"Nat Rev Clin Oncol Nov"},{"key":"1418_CR33","doi-asserted-by":"publisher","unstructured":"Yang H, Zhang Z, Li J, Wang K, Zhu W, Zeng Y. The dual role of B cells in the tumor microenvironment: implications for cancer immunology and therapy. Int J Mol Sci Nov. 2024;4(21). https:\/\/doi.org\/10.3390\/ijms252111825.","DOI":"10.3390\/ijms252111825"},{"issue":"7","key":"1418_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer Jul. 2024;10(7):627\u201342. https:\/\/doi.org\/10.1016\/j.trecan.2024.03.008.","journal-title":"Trends Cancer Jul"},{"key":"1418_CR36","doi-asserted-by":"publisher","first-page":"100981","DOI":"10.1016\/j.neo.2024.100981","volume":"50","author":"B Yu","year":"2024","unstructured":"Yu B, de Vos D, Guo X, et al. IL-6 facilitates cross-talk between epithelial cells and tumor- associated macrophages in Helicobacter pylori-linked gastric carcinogenesis. Neoplasia Apr. 2024;50:100981. https:\/\/doi.org\/10.1016\/j.neo.2024.100981.","journal-title":"Neoplasia Apr"},{"issue":"5\u20136","key":"1418_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000185506","volume":"22","author":"WF Zambuzzi","year":"2008","unstructured":"Zambuzzi WF, Granjeiro JM, Parikh K, Yuvaraj S, Peppelenbosch MP, Ferreira CV. Modulation of Src activity by low molecular weight protein tyrosine phosphatase during osteoblast differentiation. Cell Physiol Biochem. 2008;22(5\u20136):497\u2013506. https:\/\/doi.org\/10.1159\/000185506.","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"1418_CR25","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1158\/0008-5472.Can-23-2268","volume":"2","author":"R Zhang","year":"2024","unstructured":"Zhang R, Li S, Schippers K, et al. Analysis of Tumor-Associated AXIN1 missense mutations identifies variants that activate \u03b2-Catenin signaling. Cancer Res May. 2024;2(9):1443\u201359. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-2268.","journal-title":"Cancer Res May"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01418-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:49:56Z","timestamp":1770724196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-025-01418-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1418"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01418-9","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human tissue microarray (TMA) samples used in this study were collected as part of a previously approved study at The Chinese University of Hong Kong. That study involved human participants and was approved by the Clinical Research Ethics Committee of The Chinese University of Hong Kong, and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}